Positve overall survival data could lead to a label expansion for Pfizer's combination to treat metastatic ...
Increasingly common in daily practice, this is the first guideline update since 2011, aimed to improve success rates and cut complications.
A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.